United States SRES 510: A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

Status: Introduced in Senate (as of 2023-12-14)

State: United States · Session: 118 · Bill: SRES 510

Sponsors: Elizabeth A. Warren, Alex Padilla, Amy Klobuchar, Angus S. King, Bernard Sanders, Brian Schatz, Catherine Cortez Masto, Charles E. Schumer, Chris Van Hollen, Christopher S. Murphy, Cory Booker, Debbie Stabenow, Edward J. Markey, Jacklyn Rosen, Jeanne Shaheen, Jeff Merkley, John F. Reed, John K. Fetterman, John W. Hickenlooper, Jon Ossoff, Kirsten E. Gillibrand, Kyrsten Sinema, Laphonza Butler, Maggie Hassan, Maria Cantwell

View United States SRES 510 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.